These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6797699)

  • 61. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Treatment of the painful Paget's disease of the pelvis with salmon calcitonin in ambulant care. Studies in 2 cases during 26 and 19 months respectively].
    Staehelin A
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1704-5. PubMed ID: 1215961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Comparison of the histology and kinetics of radiocalcium in Paget's disease].
    Caniggia A; Gennari C
    Boll Soc Ital Biol Sper; 1973 Jul; 49(12):738-40. PubMed ID: 4791317
    [No Abstract]   [Full Text] [Related]  

  • 64. Skeletal metabolism in Paget's disease of bone.
    Krane SM
    Arthritis Rheum; 1980 Oct; 23(10):1087-94. PubMed ID: 7000079
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of Paget's disease with calcitonin.
    DeRose J; Avramides A; Baker RK; Wallach S
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract]   [Full Text] [Related]  

  • 66. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A; Zamora Madaria E; Herrera Justiniano E; Rubio Rubio JM; Gómez San Millán M; Merchante C
    Rev Iber Endocrinol; 1971; 18(107):419-42. PubMed ID: 5133441
    [No Abstract]   [Full Text] [Related]  

  • 67. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of Paget's disease of bone using synthetic salmon calcitonin administered intranasally].
    Reginster JY; Albert A; Franchimont P
    Rev Med Liege; 1986 Jan; 41(1):13-8. PubMed ID: 3952394
    [No Abstract]   [Full Text] [Related]  

  • 69. [Action of calcitonin on osteoclasts in Paget's bone disease during long term treatment (author's transl)].
    Rebel A; Basle M; Minard MF; Malkani K
    Pathol Biol (Paris); 1977 Nov; 25(9):611-6. PubMed ID: 202910
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Radiologic improvement of Paget's disease of bone by porcine calcitonin therapy: a case report].
    Sakino I; Onizuka H; Matsuura K; Eguchi M; Onizuka S
    Rinsho Hoshasen; 1984 Mar; 29(3):431-4. PubMed ID: 6748284
    [No Abstract]   [Full Text] [Related]  

  • 71. Gallium scanning in Paget's disease of bone: effect of calcitonin.
    Waxman AD; McKee D; Siemsen JK; Singer FR
    AJR Am J Roentgenol; 1980 Feb; 134(2):303-6. PubMed ID: 6766237
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical use of calcitonin].
    Sorensen OH; Friis T; Hindberg I; Lund B
    Ugeskr Laeger; 1974 Feb; 136(8):418-23. PubMed ID: 4819007
    [No Abstract]   [Full Text] [Related]  

  • 73. [Long-term therapy with calcitonin in Paget's diseases (author's transl)].
    Schmidt UJ; Trzenschik K; Abendroth K; Graner H; Ansorg A
    Z Alternsforsch; 1978; 33(2):173-83. PubMed ID: 100975
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease].
    Lo Cascio V; Lechi C; Adami S; Bianchi I; Cominacini L; Galvanini G
    Boll Soc Ital Biol Sper; 1974 Jan; 50(1-2):55-61. PubMed ID: 4425587
    [No Abstract]   [Full Text] [Related]  

  • 75. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Histologic changes in Paget's disease treated with calcitonin.
    Fornasier VL; Stapleton K; Williams CC
    Hum Pathol; 1978 Jul; 9(4):455-61. PubMed ID: 711224
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Calcitonin treatment of Paget's disease.
    Evans IM
    Lancet; 1979 Dec; 2(8154):1232-3. PubMed ID: 92633
    [No Abstract]   [Full Text] [Related]  

  • 78. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
    Reginster JY; Jeugmans-Huynen AM; Albert A; Denis D; Franchimont P
    J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deafness in Paget's diseases: effect of salmon calcitonin treatment.
    Grimaldi PM; Mohamedally SM; Woodhouse NJ
    Br Med J; 1975 Jun; 2(5973):726. PubMed ID: 1170001
    [No Abstract]   [Full Text] [Related]  

  • 80. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.